Similar articles

• Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy.

  Kimura K, Ieda M, Kanazawa H, Yagi T, Tsunoda M, Ninomiya S, Kurosawa H, Yoshimi K, Mochizuki H, Yamazaki K, Ogawa S, Fukuda K. Kimura K, et al. Circ Res. 2007 Jun 22;100(12):1755-64. doi: 10.1161/01.RES.0000269828.62250.ab. Epub 2007 May 10. Circ Res. 2007. PMID: 17495227
• Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.

  Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y. Nishida M, et al. Eur J Pharmacol. 2009 Jul 1;614(1-3):70-6. doi: 10.1016/j.ejphar.2009.04.016. Epub 2009 Apr 17. Eur J Pharmacol. 2009. PMID: 19379725
• Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.

  Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M. Schäfer S, et al. Cardiovasc Res. 2009 Apr 1;82(1):30-9. doi: 10.1093/cvr/cvp002. Epub 2009 Jan 8. Cardiovasc Res. 2009. PMID: 19131365
• Right ventricle in pulmonary hypertension.

  Voelkel NF, Natarajan R, Drake JI, Bogaard HJ. Voelkel NF, et al. Compr Physiol. 2011 Jan;1(1):525-40. doi: 10.1002/cphy.c090008. Compr Physiol. 2011. PMID: 23737184 Review.
• Right ventricular diastolic performance: compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade.

  Ferlinz J. Ferlinz J. Cathet Cardiovasc Diagn. 1998 Feb;43(2):206-43. doi: 10.1002/(sici)1097-0304(199802)43:2<206::aid-ccd22>3.0.co;2-k. Cathet Cardiovasc Diagn. 1998. PMID: 9488559 Review. No abstract available.